All Stories

  1. Cobalt(II) Complexes of 4′-Bromo-Fenamic Acid: Antioxidant Properties, Antibacterial Activity, and Interaction with DNA and Albumins
  2. Manganese(II) Complexes with 3,5–Dibromosalicylaldehyde: Characterization and Interaction Studies with DNA and Albumins
  3. Synthesis, Characterization and Biological Profile of Cationic Cobalt Complexes with First-Generation Quinolones
  4. Cobalt(II) Complexes of 4′–Nitro–Fenamic Acid: Characterization and Biological Evaluation
  5. Iron(III) Complexes with Substituted Salicylaldehydes: Synthesis, Interaction with DNA and Serum Albumins, and Antioxidant Activity
  6. Manganese(II) Complexes with Non-Steroidal Anti-Inflammatory Drugs: Structure and Biological Activity
  7. Amine-substituted heterocyclic thioamide Cu(I) and Ag(I) complexes as effective anticancer and antibacterial agents targeting the periplasm of E. coli bacteria
  8. Novel Tricarbonylrhenium-Anthrapyrazole Complexes with DNA-Binding and Antitumor Properties: In Vitro and In Vivo Pharmacokinetic Studies with 99mTc-Analogue
  9. One-Pot, Multi-Component Green Microwave-Assisted Synthesis of Bridgehead Bicyclo[4.4.0]boron Heterocycles and DNA Affinity Studies
  10. Erbium(III) complexes with fluoroquinolones: Structure and biological properties
  11. Coordination Compounds of Nickel(II) with 3,5–Dibromo–Salicylaldehyde: Structure and Interaction with Biomolecules
  12. Copper(II) complexes with non-steroidal anti-inflammatory drugs and neocuproine: Structure and biological evaluation
  13. Cu(ii) complexes with a salicylaldehyde derivative and α-diimines as co-ligands: synthesis, characterization, biological activity. Experimental and theoretical approach
  14. Coordination compounds of cobalt(ii) with carboxylate non-steroidal anti-inflammatory drugs: structure and biological profile
  15. Neutral and cationic nickel(II) complexes with substituted salicylaldehydes: Characterization, antibacterial activity, and interaction with biomacromolecules
  16. Transition metal(II) complexes with the non–steroidal anti–inflammatory drug oxaprozin: Characterization and biological profile
  17. Erbium(III) coordination compounds with substituted salicylaldehydes: Characterization and biological profile
  18. pH-Sensitive Gold Nanorods for Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Delivery and DNA-Binding Studies
  19. Iron(III) Complexes with Non-Steroidal Anti-Inflammatory Drugs: Structure, Antioxidant and Anticholinergic Activity, and Interaction with Biomolecules
  20. Metal Complexes with Naphthalene-Based Acetic Acids as Ligands: Structure and Biological Activity
  21. Effect of Arylazo Sulfones on DNA: Binding, Cleavage, Photocleavage, Molecular Docking Studies and Interaction with A375 Melanoma and Non-Cancer Cells
  22. Copper(II) complexes with 3,5–dihalogeno–salicylaldehydes: Synthesis, structure and interaction with DNA and albumins
  23. Inhibition of Cancer Cell Proliferation and Bacterial Growth by Silver(I) Complexes Bearing a CH3-Substituted Thiadiazole-Based Thioamide
  24. Copper(II) Complexes of 5–Fluoro–Salicylaldehyde: Synthesis, Characterization, Antioxidant Properties, Interaction with DNA and Serum Albumins
  25. Copper(II) complexes with 4-(diethylamino)salicylaldehyde and α-diimines: Anticancer, antioxidant, antigenotoxic effects and interaction with DNA and albumins
  26. Palladium(II) Complexes of Substituted Salicylaldehydes: Synthesis, Characterization and Investigation of Their Biological Profile
  27. In silico study of potential antiviral activity of copper(II) complexes with non–steroidal anti–inflammatory drugs on various SARS–CoV–2 target proteins
  28. Metal(II) Complexes of the Fluoroquinolone Fleroxacin: Synthesis, Characterization and Biological Profile
  29. Structure and in vitro and in silico biological activity of zinc(II) complexes with 3,5–dichloro–salicylaldehyde
  30. In vitro biological activity of copper(II) complexes with NSAIDs and nicotinamide: Characterization, DNA- and BSA-interaction study and anticancer activity
  31. Biocompatible silver(I) complexes with heterocyclic thioamide ligands for selective killing of cancer cells and high antimicrobial activity – A combined in vitro and in silico study
  32. Manganese(II) complexes of substituted salicylaldehydes and α-diimines: Synthesis, characterization and biological activity
  33. Zinc(II) complexes of 3,5–dibromo–salicylaldehyde and α–diimines: Synthesis, characterization and in vitro and in silico biological profile
  34. Stimuli-responsive spin crossover nanoparticles for drug delivery and DNA-binding studies
  35. Zinc(ii) complexes of 3-bromo-5-chloro-salicylaldehyde: characterization and biological activity
  36. Transition metal(ii) complexes of halogenated derivatives of (E)-4-(2-(pyridin-2-ylmethylene)hydrazinyl)quinazoline: structure, antioxidant activity, DNA-binding DNA photocleavage, interaction with albumin andin silicostudies
  37. Silver(i) complexes bearing heterocyclic thioamide ligands with NH2 and CF3 substituents: effect of ligand group substitution on antibacterial and anticancer properties
  38. Copper(II) complexes with non–steroidal anti–inflammatory drugs: Structural characterization, in vitro and in silico biological profile
  39. Synthesis, characterization and (in vitro and in silico) biological activity of a series of dioxouranium(VI) complexes with non-steroidal anti-inflammatory drugs
  40. Nickel(II)–meclofenamate complexes: Structure, in vitro and in silico DNA– and albumin–binding studies, antioxidant and anticholinergic activity
  41. Structure and biological profile of transition metal complexes with (E)-4-(2-(pyridin-2-ylmethylene)hydrazinyl)quinazoline
  42. Trinuclear and tetranuclear iron(III) complexes with fenamates: Structure and biological profile
  43. Copper(II) complexes with meclofenamate ligands: Structure, interaction with DNA and albumins, antioxidant and anticholinergic activity
  44. Interaction of manganese(II) with the hybrid molecule (E)-4-(2-(pyridin-2-ylmethylene)hydrazinyl)quinazoline: Structure and biological profile
  45. Synthesis, structural determination, in vitro and in silico biological evaluation of divalent or trivalent cobalt complexes with indomethacin
  46. Facile Method to Prepare pH-Sensitive PEI-Functionalized Carbon Nanotubes as Rationally Designed Vehicles for Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Delivery
  47. Zn(II) complexes of (E)-4-(2-(pyridin-2-ylmethylene)hydrazinyl)quinazoline in combination with non-steroidal anti-inflammatory drug sodium diclofenac: Structure, DNA binding and photo-cleavage studies, antioxidant activity and interaction with albumin
  48. Silver complexes with heterocyclic thioamide and tertiary arylphosphane ligands: Synthesis, crystal structures, in vitro and in silico antibacterial and cytotoxic activity, and interaction with DNA
  49. Structure and biological evaluation of pyridine-2-carboxamidine copper(II) complex resulting from N′-(4-nitrophenylsulfonyloxy)2-pyridine-carboxamidoxime
  50. Copper(II) and zinc(II) coordination compounds of non-steroidal anti-inflammatory drugs: Structural features and antioxidant activity
  51. Transition metal complexes with a novel guanine-based (E)-2-(2-(pyridin-2-ylmethylene)hydrazinyl)quinazolin-4(3H)-one: Synthesis, characterization, interaction with DNA and albumins and antioxidant activity
  52. p-Pyridinyl oxime carbamates: synthesis, DNA binding, DNA photocleaving activity and theoretical photodegradation studies
  53. Manganese(II) coordination compounds of carboxylate non-steroidal anti-inflammatory drugs
  54. Novel copper(ii) complexes with fenamates and isonicotinamide: structure and properties, and interactions with DNA and serum albumin
  55. A palladium(II) complex with the Schiff base 4-chloro-2-(N-ethyliminomethyl)-phenol: Synthesis, structural characterization, and in vitro and in silico biological activity studies
  56. Bi- and trinuclear copper(I) compounds of 2,2,5,5-tetramethyl-imidazolidine-4-thione and 1,2-bis(diphenylphosphano)ethane: Synthesis, crystal structures, in vitro and in silico study of antibacterial activity and interaction with DNA and albumins
  57. Cobalt(II) complexes with the non-steroidal anti-inflammatory drug diclofenac and nitrogen-donor ligands
  58. Synthesis, characterization and biological activity of Zn coordination compounds with the quinolone gatifloxacin
  59. Zinc-oxaprozin compounds: Synthesis, structure and biological activity
  60. Homoleptic and heteroleptic silver(I) complexes bearing diphosphane and thioamide ligands: Synthesis, structures, DNA interactions and antibacterial activity studies
  61. Organometallic rhenium tricarbonyl–enrofloxacin and –levofloxacin complexes: synthesis, albumin-binding, DNA-interaction and cell viability studies
  62. Palladium(II) complexes with salicylaldehyde ligands: Synthesis, characterization, structure, in vitro and in silico study of the interaction with calf-thymus DNA and albumins
  63. Manganese coordination compounds of mefenamic acid: In vitro screening and in silico prediction of biological activity
  64. Manganese(II) complexes of tolfenamic acid or naproxen in polymeric structures or encapsulated in [15-MC-5] manganese(III) metallacrowns: Structure and biological activity
  65. Copper(II) diclofenac complexes: Synthesis, structural studies and interaction with albumins and calf-thymus DNA
  66. Heterocyclic thioamide/phosphine mixed-ligand silver(I) complexes: Synthesis, molecular structures, DNA-binding properties and antibacterial activity
  67. Manganese(II) complexes of the quinolone family member flumequine: Structure, antimicrobial activity and affinity for albumins and calf-thymus DNA
  68. A step-ladder manganese(iii) metallacrown hosting mefenamic acid and a manganese(ii)–mefanamato complex: synthesis, characterization and cytotoxic activity
  69. Ruthenium–arene complexes with NSAIDs: synthesis, characterization and bioactivity
  70. Extending the family of quinolone antibacterials to new copper derivatives: self-assembly, structural and topological features, catalytic and biological activity
  71. Manganese(ii) complexes with the non-steroidal anti-inflammatory drugs naproxen and mefenamic acid: synthesis, structure, antioxidant capacity, and interaction with albumins and DNA
  72. Nickel(II)-indomethacin mixed-ligand complexes: Synthesis, characterization, antioxidant activity and interaction with DNA and albumins
  73. Interaction of zinc(II) with the non-steroidal anti-inflammatory drug niflumic acid
  74. Toward Multifunctional Materials Incorporating Stepladder Manganese(III) Inverse-[9-MC-3]-Metallacrowns and Anti-Inflammatory Drugs
  75. Zinc complexes of diflunisal: Synthesis, characterization, structure, antioxidant activity, and in vitro and in silico study of the interaction with DNA and albumins
  76. Synthesis, structural, thermal characterization and interaction with calf-thymus DNA and albumins of cationic Ni(II) complexes with 2,2′-dipyridylamine and salicylaldehydes
  77. Nickel(ii)–naproxen mixed-ligand complexes: synthesis, structure, antioxidant activity and interaction with albumins and calf-thymus DNA
  78. Copper(I) halide complexes of 2,2,5,5-tetramethyl-imidazolidine-4-thione: Synthesis, structures, luminescence, thermal stability and interaction with DNA
  79. Copper(II) complexes with gatifloxacin
  80. Zinc complexes of flufenamic acid: Characterization and biological evaluation
  81. Ni(II) complexes with 2,2-dipyridylamine and salicylaldehydes: Synthesis, crystal structure and interaction with calf-thymus DNA and albumins
  82. Nickel(II) complexes of flufenamic acid: Characterization, structure and interaction with DNA and albumins
  83. Nickel(II) complexes of the non-steroidal anti-inflammatory drug tolfenamic acid: Synthesis, structure, antioxidant activity and interaction with albumins and calf-thymus DNA
  84. Cobalt(II) complexes of sparfloxacin
  85. Nickel-diflunisal complexes: synthesis, characterization, in vitro antioxidant activity and interaction with DNA and albumins
  86. Characterization and biological properties of copper(II)-ketoprofen complexes
  87. Dinuclear copper(I) complexes of N-methylbenzothiazole-2-thione: synthesis, structures, antibacterial activity and DNA interaction
  88. Co-NSAIDs
  89. Synthesis, characterization and biological evaluation of 99m Tc/Re–tricarbonyl quinolone complexes
  90. Pyridine and p-Nitrophenyl Oxime Esters with Possible Photochemotherapeutic Activity: Synthesis, DNA Photocleavage and DNA Binding Studies
  91. Alkyl and aryl sulfonyl p-pyridine ethanone oximes are efficient DNA photo-cleavage agents
  92. Cd - 5-Cl-saloH
  93. Cd - 5-Br-saloH
  94. Evaluation of O-alkyl and aryl sulfonyl aromatic and heteroaromatic amidoximes as novel potent DNA photo-cleavers
  95. Structure and biological activities of metal complexes of flumequine
  96. New copper(ii) complexes of the anti-inflammatory drug mefenamic acid: a concerted study including synthesis, physicochemical characterization and their biological evaluation
  97. On the Complexity of Dynamic Mechanism Design
  98. Copper(II) Inverse-[9-Metallacrown-3] Compounds Accommodating ­Nitrato or Diclofenac Ligands: Structure, Magnetism, and Biological Activity
  99. Cd - 5-nitro-saloH
  100. Mn-diclofenac complexes
  101. Copper-tolfenamato complexes
  102. Mn3-diclofenac
  103. Ni - mefanamato complexes
  104. Manganese(II)–sparfloxacinato complexes
  105. Cobalt-oxolinato complexes
  106. Cu - saloH
  107. Copper(II)–indomethacin complexes
  108. Thermal analysis and structural characterization of copper(II) complexes with salicyladehydes
  109. Cobalt(II) complexes of enrofloxacin
  110. Synthesis, thermal analysis, and spectroscopic and structural characterizations of tetranuclear nickel(II) cubane-type clusters with 2-hydroxybenzaldehydes or 2-hydroxyphenones
  111. Synthesis, characterization, thermal and DNA-binding properties of new zinc complexes with 2-hydroxyphenones
  112. Zinc-tolfenamato
  113. Manganese(II) complexes of tolfenamic acid
  114. Zinc complexes of mefenamic acid
  115. Zn saloH
  116. Nickel complexes of diclofenac
  117. New Uses for Old Drugs: Attempts to Convert Quinolone Antibacterials into Potential Anticancer Agents Containing Ruthenium
  118. Copper(II) complexes of flufenamic acid
  119. Manganese(II) complexes of niflumic acid
  120. Zinc complexes of oxolinic acid, flumequine, enrofloxacin
  121. Manganese(II) complexes of oxolinic acid and enrofloxacin
  122. Metal complexes of quinolones or NSAIDs: Perspective
  123. Zinc complexes of flumequine
  124. Copper complexes with ofloxacin and norfloxacin - synthesis, structure na bioactivity
  125. Copper(II) complexes of flumequine
  126. A [24-MC-6] Zinc Metallacoronate with a Nonsteroidal Antiinflammatory Drug as the Constructing Ligand
  127. First Palladium(II) and Platinum(II) Complexes from Employment of 2,6-Diacetylpyridine Dioxime: Synthesis, Structural and Spectroscopic Characterization, and Biological Evaluation
  128. Cobalt(II)-tolfenamato complexes
  129. Cobalt - naproxen
  130. Zinc complexes of tolfenamic acid
  131. Copper - diflunisal
  132. Nickel–quinolones-bipyam complexes
  133. Copper(II) complexes of naproxen / diclofenac
  134. Copper(ii) complexes of mefenamic acid
  135. Zinc complexes of sparfoxacin - levofloxacin
  136. Nickel complexes of enrofloxacin
  137. Nickel complexes of flumequine
  138. Metal - sparfloxacin complexes
  139. Zinc(II) complexes of enrofloxacin
  140. Nickel complexes of oxolinic acid
  141. Cobalt(ii) complexes of mefenamic acid
  142. Nickel complexes of sparfloxacin
  143. Structure and DNA-binding properties of bis(quinolonato)bis(pyridine)zinc(II) complexes
  144. Structure, cyclic voltammetry and DNA-binding properties of the bis(pyridine)bis(sparfloxacinato)nickel(II) complex
  145. Characterization and DNA-interaction studies of 1,1-dicyano-2,2-ethylene dithiolate Ni(II) mixed-ligand complexes with 2-amino-5-methyl thiazole, 2-amino-2-thiazoline and imidazole. Crystal structure of [Ni(i-MNT)(2a-5mt)2]
  146. Zinc-oxolinato complexes
  147. Mononuclear metal complexes with ciprofloxacin: Synthesis, characterization and DNA-binding properties
  148. Magnesium complexes of ciprofloxacin
  149. Structure, antimicrobial activity and DNA-binding properties of the cobalt(II)–sparfloxacin complex
  150. Mononuclear metal complexes of the second-generation quinolone antibacterial agent enrofloxacin: Synthesis, structure, antibacterial activity and interaction with DNA
  151. Copper(II) complexes with sparfloxacin and nitrogen-donor heterocyclic ligands: Structure–activity relationship
  152. Novel Copper(II) Complex ofN-Propyl-norfloxacin and 1,10-Phenanthroline with Enhanced Antileukemic and DNA Nuclease Activities
  153. Synthesis, characterization and DNA-binding of the mononuclear dioxouranium(VI) complex with ciprofloxacin
  154. Mononuclear dioxomolybdenum(VI) complexes with the quinolones enrofloxacin and sparfloxacin: Synthesis, structure, antibacterial activity and interaction with DNA
  155. Mononuclear copper(II) complexes with quinolones and nitrogen-donor heterocyclic ligands: Synthesis, characterization, biological activity and interaction with DNA
  156. Neutral mononuclear dioxomolybdenum(VI) and dioxouranium(VI) complexes of oxolinic acid: Characterization and biological evaluation
  157. Synthesis, characterization and interaction with DNA of mononuclear metal complexes with oxolinic acid
  158. Metal complexes with the quinolone antibacterial agent N-propyl-norfloxacin: Synthesis, structure and bioactivity
  159. Synthesis, characterization, antibacterial activity, and interaction with DNA of the vanadyl-enrofloxacin complex
  160. Metal-pipemidato complexes
  161. Structure and biological properties of the copper(II) complex with the quinolone antibacterial drug N-propyl-norfloxacin and 2,2′-bipyridine
  162. Synthesis, structure and biological activity of copper(II) complexes with oxolinic acid
  163. Copper-enrofloxacin complexes
  164. Cu(II) - sparfloxacin
  165. Metal-piroxicam complexes
  166. An Unprecedented Trinuclear Structure Involving Two High-Spin and One Spin-Crossover Iron(II) Centers
  167. Host-Guest Interaction of 12-MC-4, 15-MC-5, and Fused 12-MC-4 Metallacrowns with Mononuclear and Binuclear Carboxylato Complexes: Structure and Magnetic Behavior
  168. Preparation of Site-Differentiated Mixed Ligand and Mixed Ligand/Mixed Metal Metallacrowns
  169. Copper(II) complexes with phenoxyalkanoic acids and nitrogen donor heterocyclic ligands: structure and bioactivity
  170. Structurally Diverse Copper(II)−Carboxylato Complexes:  Neutral and Ionic Mononuclear Structures and a Novel Binuclear Structure
  171. Ni metallacrowns hosting a carboxylic herbicide
  172. CuII-herbicide complexes: structure and bioactivity
  173. Structurally diverse copper(II) herbicide complexes: mono- and bi-nuclear neutral or cationic complexes
  174. Mn(II) - MCPA